Zydus Lifesciences Limited — Important, 24-10-2024: Updates

Zydus Lifesciences has received approval for the merger of its wholly-owned subsidiary, Nesher Pharmaceuticals, with Zydus Pharmaceuticals USA Inc., effective October 25, 2024. Nesher, which has been inactive and recognized as "Discontinued Operations," will not affect the company's business. This merger aligns with Zydus's strategy to simplify its corporate structure. Nesher's operating income for the FY 23-24 was nil, with minimal net worth impact on the consolidated finances.